Icariin
- Generic Name
- Icariin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C33H40O15
- CAS Number
- 489-32-7
- Unique Ingredient Identifier
- VNM47R2QSQ
- Background
Icariin has been investigated for the basic science of the Pharmacokinetic Profile of Icariin in Humans.
- Associated Conditions
- -
- Associated Therapies
- -
Icariin to Prevent Corticosteroid-related Memory Changes
Phase 1
Completed
- Conditions
- the Pharmacokinetic Profile of Icariin in Humans
- Interventions
- Dietary Supplement: Matching placeboDrug: Icariin
- First Posted Date
- 2014-04-11
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT02112123
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
- First Posted Date
- 2013-11-08
- Last Posted Date
- 2017-04-19
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT01979133
- Locations
- 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath